Alexandria Real Estate (ARE) EVP reports 48,698 directly held shares
Rhea-AI Filing Summary
Alexandria Real Estate Equities, Inc. executive reports share holdings. EVP - Co-Lead - Life Science Jenna R. Foger filed an initial ownership report showing beneficial ownership of 48,698 shares of Alexandria Real Estate Equities, Inc. common stock. The filing lists these shares as held directly, with no derivative securities reported.
Positive
- None.
Negative
- None.
Insider Trade Summary
1 transaction reported
Mixed
1 txn
Insider
Foger Jenna R.
Role
EVP - Co-Lead - Life Science
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| holding | Common Stock | -- | -- | -- |
Holdings After Transaction:
Common Stock — 48,698 shares (Direct)
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What does the Alexandria Real Estate (ARE) Form 3 filed by Jenna R. Foger report?
The Form 3 reports that Jenna R. Foger, an EVP and Co-Lead - Life Science at Alexandria Real Estate Equities, beneficially owns 48,698 shares of the company’s common stock, held directly, with no derivative securities listed in this initial ownership statement.
What is Jenna R. Foger’s role at Alexandria Real Estate (ARE) in this Form 3?
In the Form 3, Jenna R. Foger is identified as an officer of Alexandria Real Estate Equities, Inc. with the title “EVP - Co-Lead - Life Science.” She is not marked as a director or 10% owner, only as an executive officer of the company.
Does the Jenna R. Foger Form 3 for Alexandria Real Estate (ARE) show any derivative securities?
The Form 3 lists no derivative securities for Jenna R. Foger. Table I shows 48,698 shares of common stock held directly, while Table II, which would disclose options or other derivatives, contains no entries in this filing for derivative holdings.
Is Jenna R. Foger a 10% owner of Alexandria Real Estate (ARE) according to this Form 3?
The Form 3 does not classify Jenna R. Foger as a 10% owner of Alexandria Real Estate Equities, Inc. The filing marks her solely as an officer, serving as EVP - Co-Lead - Life Science, with reported beneficial ownership of 48,698 common shares.